Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYRN

Cyren (CYRN) Stock Price, News & Analysis

Cyren logo

About Cyren Stock (NASDAQ:CYRN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.21
$0.92
52-Week Range
N/A
Volume
1.15 million shs
Average Volume
1.43 million shs
Market Capitalization
$1.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CYREN Ltd. engages in the provision of cloud delivered Software-as-a-Service cybersecurity solutions that protect businesses, employees and customers against threats from email, files, and the web. It operates through the following geographical segments: Israel, United States, Germany and Other. Its products include inbox security for office 365, threat indepth, and incident response service The company was founded by Amir Lev, Gideon Mantel, and Nahum Sharfman on February 10, 1991 and is headquartered in Herzliya, Israel.

Receive CYRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyren and its competitors with MarketBeat's FREE daily newsletter.

CYRN Stock News Headlines

Peyto Exploration&Development Corp (PEY)
Trump’s Bitcoin Reserve is No Accident…
Remember when they said crypto would never go mainstream? Well, something remarkable has happened… BlackRock, the world's largest asset manager, is now buying Bitcoin through ETFs. Fidelity, Goldman Sachs, and Citadel have joined them. We have the most pro-crypto administration in history. And the regulatory barriers are finally falling.
Why Is Cyren (CYRN) Stock Down 27% Today?
Cyren Announces Nasdaq Delisting Determination
Cyren Announces Liquidation
Why Is Cyren (CYRN) Stock Up 43% Today?
See More Headlines

CYRN Stock Analysis - Frequently Asked Questions

Cyren Ltd. (NASDAQ:CYRN) announced its earnings results on Monday, November, 15th. The technology company reported ($0.06) EPS for the quarter, meeting the consensus estimate of ($0.06). The technology company had revenue of $7.46 million for the quarter. Cyren had a negative trailing twelve-month return on equity of 206.16% and a negative net margin of 123.96%.

Cyren subsidiaries include these companies: eleven GmbH, FRISK Software International, Authentium, Wingtra, Cyren Gesellschaft mbH, Cyren Iceland hf, Cyren Inc., and Cyren UK Ltd..

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyren investors own include Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Vaxart (VXRT), Acasti Pharma (ACST), iBio (IBIO), Oragenics (OGEN) and OpGen (OPGN).

Company Calendar

Last Earnings
11/15/2021
Today
5/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRN
Employees
200
Year Founded
1991

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-23,040,000.00
Net Margins
-123.96%
Pretax Margin
-94.37%

Debt

Sales & Book Value

Annual Sales
$31.19 million
Price / Cash Flow
N/A
Book Value
$3.05 per share
Price / Book
N/A

Miscellaneous

Free Float
7,539,000
Market Cap
$1.70 million
Optionable
Not Optionable
Beta
0.83

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:CYRN) was last updated on 5/10/2025 by MarketBeat.com Staff
From Our Partners